Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H31NO3 |
| Molecular Weight | 357.4864 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C[C@@H]2CCC[C@H](C1)[C@@H]2OC(=O)[C@@](O)(C3CCCC3)C4=CC=CC=C4
InChI
InChIKey=ROZOEEGFKDFEFP-DJBOQGILSA-N
InChI=1S/C22H31NO3/c1-23-14-16-8-7-9-17(15-23)20(16)26-21(24)22(25,19-12-5-6-13-19)18-10-3-2-4-11-18/h2-4,10-11,16-17,19-20,25H,5-9,12-15H2,1H3/t16?,17?,20?,22-/m0/s1
Levophencynonate is the active enantiomer of phencynonate. Levophencynonate is an anticholinergic agent which can prevent acute motion sickness with an efficacy similar to scopolamine. It will take effect by competitive binding to central muscarinic acetylcholine receptors. In April 2017 levophencynonate was in preregistration phase for the vertigo treatment in China.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4TNV157KEQ
Created by
admin on Sat Dec 16 10:25:46 GMT 2023 , Edited by admin on Sat Dec 16 10:25:46 GMT 2023
|
PRIMARY | |||
|
25055665
Created by
admin on Sat Dec 16 10:25:46 GMT 2023 , Edited by admin on Sat Dec 16 10:25:46 GMT 2023
|
PRIMARY | |||
|
230313-75-4
Created by
admin on Sat Dec 16 10:25:46 GMT 2023 , Edited by admin on Sat Dec 16 10:25:46 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
